Itorate Forte Capsule contains Itraconazole 200 mg, a broad-spectrum triazole antifungal agent used primarily for the treatment of various fungal infections. Itraconazole works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting cell membrane integrity and leading to fungal cell death. It is indicated for the management of systemic and superficial mycoses, including aspergillosis, blastomycosis, histoplasmosis, onychomycosis, and candidiasis. The capsule formulation ensures adequate bioavailability and convenient oral administration. Itorate Forte is typically prescribed for adults and should be taken with food to enhance absorption. Dosage and duration depend on the type and severity of infection, and treatment should be guided by clinical response and laboratory findings. Caution is advised in patients with hepatic impairment, congestive heart failure, or those receiving concomitant medications metabolized via the cytochrome P450 system, due to potential drug interactions. Common adverse effects include gastrointestinal disturbances, headache, and rash, while rare but serious effects may involve hepatotoxicity and cardiac issues. Regular monitoring of liver function tests is recommended during prolonged therapy. Itorate Forte Capsule should be used under medical supervision to ensure safety and efficacy.